19021916|t|Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.
19021916|a|alpha-synuclein (alpha-syn) is a main component of Lewy bodies (LB) that occur in many neurodegenerative diseases, including Parkinson's disease (PD), dementia with LB (DLB) and multi-system atrophy. alpha-syn mutations or amplifications are responsible for a subset of autosomal dominant familial PD cases, and overexpression causes neurodegeneration and motor disturbances in animals. To investigate mechanisms for alpha-syn accumulation and toxicity, we studied a mouse model of lysosomal enzyme cathepsin D (CD) deficiency, and found extensive accumulation of endogenous alpha-syn in neurons without overabundance of alpha-syn mRNA. In addition to impaired macroautophagy, CD deficiency reduced proteasome activity, suggesting an essential role for lysosomal CD function in regulating multiple proteolytic pathways that are important for alpha-syn metabolism. Conversely, CD overexpression reduces alpha-syn aggregation and is neuroprotective against alpha-syn overexpression-induced cell death in vitro. In a C. elegans model, CD deficiency exacerbates alpha-syn accumulation while its overexpression is protective against alpha-syn-induced dopaminergic neurodegeneration. Mutated CD with diminished enzymatic activity or overexpression of cathepsins B (CB) or L (CL) is not protective in the worm model, indicating a unique requirement for enzymatically active CD. Our data identify a conserved CD function in alpha-syn degradation and identify CD as a novel target for LB disease therapeutics.
19021916	17	28	cathepsin D	Gene	13033
19021916	46	61	alpha-synuclein	Gene	20617
19021916	78	86	toxicity	Disease	MESH:D064420
19021916	88	103	alpha-synuclein	Gene	20617
19021916	105	114	alpha-syn	Gene	20617
19021916	139	150	Lewy bodies	Disease	MESH:D020961
19021916	152	154	LB	Disease	MESH:D020961
19021916	175	201	neurodegenerative diseases	Disease	MESH:D019636
19021916	213	232	Parkinson's disease	Disease	MESH:D010300
19021916	234	236	PD	Disease	MESH:D010300
19021916	239	255	dementia with LB	Disease	MESH:D020961
19021916	257	260	DLB	Disease	MESH:D020961
19021916	266	286	multi-system atrophy	Disease	MESH:D019578
19021916	288	297	alpha-syn	Gene	20617
19021916	386	388	PD	Disease	MESH:D010300
19021916	422	439	neurodegeneration	Disease	MESH:D019636
19021916	444	462	motor disturbances	Disease	MESH:D014832
19021916	505	514	alpha-syn	Gene	20617
19021916	532	540	toxicity	Disease	MESH:D064420
19021916	555	560	mouse	Species	10090
19021916	587	598	cathepsin D	Gene	13033
19021916	600	602	CD	Gene	13033
19021916	663	672	alpha-syn	Gene	20617
19021916	709	718	alpha-syn	Gene	20617
19021916	765	767	CD	Gene	13033
19021916	851	853	CD	Gene	13033
19021916	930	939	alpha-syn	Gene	20617
19021916	964	966	CD	Gene	13033
19021916	990	999	alpha-syn	Gene	20617
19021916	1043	1052	alpha-syn	Gene	20617
19021916	1102	1112	C. elegans	Species	328850
19021916	1120	1122	CD	Gene	13033
19021916	1146	1155	alpha-syn	Gene	20617
19021916	1216	1225	alpha-syn	Gene	20617
19021916	1234	1264	dopaminergic neurodegeneration	Disease	MESH:D009422
19021916	1274	1276	CD	Gene	13033
19021916	1455	1457	CD	Gene	13033
19021916	1489	1491	CD	Gene	13033
19021916	1504	1513	alpha-syn	Gene	20617
19021916	1564	1574	LB disease	Disease	MESH:D020961
19021916	Association	MESH:D019578	20617
19021916	Association	MESH:D014832	20617
19021916	Association	MESH:D020961	13033
19021916	Association	MESH:D010300	20617
19021916	Association	MESH:D009422	13033
19021916	Association	MESH:D019636	20617
19021916	Negative_Correlation	13033	20617
19021916	Association	MESH:D064420	13033
19021916	Positive_Correlation	MESH:D009422	20617
19021916	Association	MESH:D020961	20617

